What is myelodysplastic anemia?
Myelodyspllastic anemia is the most important feature of a larger bone marrow disorder called myelodysplastic syndrome. The disorder affects how bone marrow stem cells produce and release new blood cells. Anemia is most related to the abnormal production of plates. Unripe plates do not fully develop before they get into the bloodstream, which is unable to clot. Patients who have myelodysplastic anemia usually need to take drugs and hormones to prevent excessive bleeding and fight the symptoms of fatigue and shortness of breath. Bone marrow transplantation is needed in serious cases to prevent potentially fatal complications.
Bone marrow produces stem cells that support the development of platelets and red and white blood cells. In the case of myelodysplastic syndrome, the blood cells die either before reaching maturity or incorrectly when they reach the bloodstream. The result is not enough space for prospering healthy blood cells. Men of myelodysplastic anemia have no noneClear causes, but doctors believe that chemotherapy, radiation, environmental toxins and genetic factors can contribute to defects of bone marrow. The average age of onset of symptoms is 70, although the incidents have been reported in patients of all age groups.
The most common symptoms of myelodysplastic anemia are pale skin, easy bruising and excessive bleeding from seemingly small wounds. Women of reproductive age may have particularly long or severe bleeding during menstrual periods. Due to insufficient blood supply, people often get tired and have chronic breathing problems. As a result of the low number of white blood cells, other health problems such as frequent infections and chronic pain may occur. Finally, the untreated case of myelodysplastic anemia increases the likelihood of leukemia development.
People who show signs and are chronically ill should be evaluated by doctors. DoctorIt can perform a physical test, ask for symptoms and collect blood sample for laboratory testing. The complete blood count is collected and analyzed to check the unusually low number of healthy platelet. If blood tests are suspicious, myelodysplastic anemia may be needed by bone marrow biopsy.
Since there is no reliable medicine for myelodysplastic anemia, treatment is usually aimed at mastering symptoms. Hormones of synthetic growth factor can be administered to increase the total number of blood cells produced inside the bones. Other medicines are also administered to combat infection, thickening and stabilizing heart rate. Patients who have a dangerously low number of plates, despite taking drugs, can be scheduled for bone marrow transplantation to replace non -functional stem cells. The views for patients after surgery differ, but many people see a huge improvement in their symptoms and quality of life.